TPWA
FENC icon

TRUE Private Wealth Advisors’s Fennec Pharmaceuticals FENC Stock Holding History

TRUE Private Wealth Advisors’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-500
Closed -$4K – 705
2020
Q2 		$4K Buy
+500
New +$3.72K ﹤0.01% 580

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

TRUE Private Wealth Advisors's FENC Position: Q3 2020 in Review

TRUE Private Wealth Advisors sold out of Fennec Pharmaceuticals (FENC) in Q3 2020, closing a stake of 500 shares — an estimated $4K sold.

TRUE Private Wealth Advisors first reported a position in FENC in Q2 2020 and held it in 1 quarter. The position peaked at $4K in Q2 2020. 55 funds tracked by Wall St. Rank hold FENC as of Q3 2020.

  • TRUE Private Wealth Advisors reported no remaining Fennec Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • TRUE Private Wealth Advisors sold 500 Fennec Pharmaceuticals shares in Q3 2020, an estimated $4K.
  • TRUE Private Wealth Advisors first reported a position in Fennec Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • TRUE Private Wealth Advisors's Fennec Pharmaceuticals position peaked at $4K in Q2 2020.
  • 55 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2020.

Based on TRUE Private Wealth Advisors's 13F filing for Q3 2020, filed 9 Oct 2020.